Back to results
US 2004/0204455 A1Published application
Piperidine derivative rennin inhibitors
OwnerWayne Livingston Cody, Jeremy John Edmunds +2inventors
InventorsWayne Livingston Cody, Jeremy John Edmunds, Daniel Dale Holsworth, Noel Aaron Powell
Life of this patent
Estimating the term…
Abstract
Disclosed are piperidine derivatives, their manufacture and use as inhibitors of renin.
Claims67
A compound of Formula I
- 54
- or a pharmaceutically acceptable salt thereof, wherein
- R1 and R2 are independently hydrogen or unsubstituted C1-C3 alkyl;
- R3 is hydrogen, oxo, or thioxo;
- R0 is hydrogen or unsubstituted C1-C3 alkyl provided that when R3 is oxo or thioxo R0 is absent;
- R4, R5, R6, and R7 are independently hydrogen, halogen, carboxyl, substituted or unsubstituted C1-C3 alkoxy, or substituted or unsubstituted C1-C3 alkyl;
- Q is —NR8—(CH2)0-6—, —NR9—C(O)—(CH2)0-6—, wherein 1 to 3 nonadjacent methylene units are replaced with O, NR11, S or a combination thereof;
- T is substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, or substituted or unsubstituted C1-C12 alkyl
- W is absent, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl;
- Z is —(CH2)0-6-cycloalkylene-(CH2)0-6— wherein 0 to 6 nonadjacent methylene units are replaced with O, NR12, S or a combination thereof, —(CH2)0-6-heterocycloalkylene-(CH2)0-6— wherein 0 to 6 nonadjacent methylene units are replaced with O, NR12, S or a combination thereof, —(CH2)0-6-arylene-(CH2)0-6— wherein 0 to 6 nonadjacent methylene units are replaced with O, NR12, S or a combination thereof, —(CH2)0-6-heteroarylene-(CH2)0-6— wherein 0 to 6 nonadjacent methylene units are replaced with O, NR12, S or a combination thereof, —(CH2)0-6—C(O)—NR11—(CH2)0-6— wherein 0 to 6 nonadjacent methylene units are replaced with O, NR12, S or a combination thereof, —(CH2)0-6—NR11—C(O)—(CH2)0-6— wherein 0 to 6 nonadjacent methylene units are replaced with O, NR12, S or a combination thereof,
- 55
- wherein 1 to 6 nonadjacent
- 56
- units are replaced with O, NR12, S or a combination thereof, or
- Z, when W is absent, is hydroxyl, substituted or unsubstituted C1-C12 alkyl wherein 1 to 6 nonadjacent methylene units are replaced with O, NR16, S or a combination thereof, or —(CH2)0-6—C(O)—NR16-(CH2)0-5—CH3 wherein 0 to 6 nonadjacent methylene units are replaced with O, NR16, S or a combination thereof;
- R8, R9 and R10 are independently hydrogen or substituted or unsubstituted C1-C3 alkyl;
- R11 and R12 are independently substituted or unsubstituted C1-C3 alkyl;
- and
- R14 and R15 are independently hydrogen, substituted or unsubstituted C1-C3 alkoxy, substituted or unsubstituted C1-C3 alkyl, unsubstituted C1-C12 alkyl wherein 1 to 6 nonadjacent methylene units are replaced with 0, or R14 and R15 together with the carbon to which they are attached form a 3- to 6-membered cycloalkylene or heterocycloalkylene ring;
- and
- R16 is substituted or unsubstituted C1-C3 alkyl or hydrogen.
18 more elements
A compound of Formula IV or V
- 60
- or a pharmaceutically acceptable salt thereof, wherein
- T is substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl;
- W is substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl;
- and
- R17 is hydrogen or C1-C3 alkyl.
3 more elements
The compound
- (4-{4-[3-(2-methoxy-benzyloxy)-propoxy]-phenyl}-piperidin-3-yl)-naphthalen-2-ylmethyl-amine,
- (4-{4-[3-(2-methoxy-benzyloxy)-propoxy]-phenyl}-piperidin-3-yl)-(6-methoxy-naphthalen-2-ylmethyl)-amine,
- (4-{4-[3-(2-methoxy-benzyloxy)-propoxy]-phenyl}-piperidin-3-yl)-quinolin-7-ylmethyl-amine,
- (4-{4-[3-(2-methoxy-benzyloxy)-propoxy]-phenyl}-piperidin-3-yl)-(1,2,3,4-tetrahydro-quinolin-7-ylmethyl)-amine,
- (4-{4-[3-(2-methoxy-benzyloxy)-propoxy]-phenyl}-piperidin-3-yl)-methyl-naphthalen-2-ylmethyl-amine,
- 6-[(4-{4-[3-(2-methoxy-benzyloxy)-propoxy]-phenyl}-piperidin-3-ylamino)-methyl]-naphthalen-2-ol,
- benzofuran-5-ylmethyl-(4-{4-[3-(2-methoxy-benzyloxy)-propoxy]-phenyl}-piperidin-3-yl)-amine,
- (1H-indol-5-ylmethyl)-(4-{4-[3-(2-methoxy-benzyloxy)-propoxy]-phenyl}-piperidin-3-yl)-amine;
- 6-[(4-[3-(2-methoxy-benzyloxy)-propoxyl]-phenyl}-piperidin-3-ylamino)-methyl]-naphthalene-1-carboxylic acid methyl ester;
- 6-[(4-[4-(2-methoxy-benzyloxy)-propoxyl]-phenyl}-piperidin-3-ylamino)-methyl]-naphthalene-1-carboxylic acid;
- naphthalene-1-carboxylic acid (4-{4-[3-(2-methoxy-benzyloxy)-propoxy]-phenyl}-piperidin-3-yl)-amide;
- 6-[(4-{4-[3-(2-methoxy-benyloxy)-propoxy]-phenyl}-piperidin-3-ylamino)-methyl]-naphthalene-2-carboxylic acid methyl ester;
- (4-{4-[3-(2-fluoro-benzyloxy)-propoxy]-phenyl}-piperidin-3-yl)-quinolin-7-ylmethyl-amine;
- 6-[(4-{4-[3-(2-fluoro-benyloxy)-propoxy]-phenyl}-piperidin-3-ylamino)-methyl]-naphthalene-2-carboxylic acid methyl ester;
- 6-[(4-{4-[3-(2-fluoro-benyloxy)-propoxy]-phenyl}-piperidin-3-ylamino)-methyl]-naphthalene-2-carboxylic acid;
- 6-[(4-{4-[3-(2-fluoro-benzyloxy)-propoxy]-phenyl}-piperidin-3-ylamino)-methyl]-pyridine-2-carboxylic acid methyl ester;
- naphthalene-2-sulfonic acid (4-{4-[3-(2-fluoro-benzyloxy)-propoxy]-phenyl}-piperidin-3-yl)-amide;
- (4-{4-[3-(2-fluoro-benzyloxy)-propoxy]-phenyl}-piperidin-3-yl)-(4-fluoro-3-trifluoromethyl-benzyl)-amine;
- {3-[(4-{4-[3-(2-fluoro-benzyloxy)-propoxy]-phenyl}-piperidin-3-ylamino)-methyl]-phenoxy}-acetic acid methyl ester;
- 1-(2-{3-[(4-{4-[3-(2-fluoro-benzyloxy)-propoxy]-phenyl}-piperidin-3-ylamino)-methyl]-phenoxy}-ethyl)-pyrrolidine-2,5-dione;
- 1-(2-{3-[(4-{4-[3-(2-fluoro-benzyloxy)-propoxy]-phenyl}-piperidin-3-ylamino)-methyl]-phenoxy}-ethyl)-pyrrolidine-2-one;
- 3-[(1-dimethylcarbamoylmethyl-1, 2, 3, 4-tetrahydro-quinoline-7-carbonyl)-amino]-4-{4-[3-(2-methoxy-benzyloxy)-propoxy]-phenyl}-piperidine-1-carboxylic acid tert-butyl ester;
- or
- [1-(2-dimethylamino-ethyl)-1,2,3,4-tetrahydro-quinolin-7-ylmethyl]-(4-{4-[3-(2-methoxybenzyloxy)-propoxy]-phenyl}-piperidin-3-yl)-amine.
21 more elements
Dependencies are inferred from the claim text.